Similar in size, shape and thickness to a postage stamp, PharmFilm is a truly unique drug delivery platform that represents a leap forward in how pharmaceutical products are developed and administered. PharmFilm benefits both patient and pharmaceutical provider by fostering a more convenient, precise and potentially safer means for delivering prescription drugs.

MonoSol Rx and PharmFilm Drug Delivery Technology

Latest News
Oct 06 2014
US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent
Aug 18 2014
MonoSol Rx Launches Clinical Study of MSRX-110 Oral Film for Testosterone Replacement
Jul 22 2014
MonoSol Rx Enters Into Exclusive Licensing Agreement with Galena Biopharma for Zuplenz® Oral Soluble Film
PharmFilm Advantages

MonoSol Rx has cemented a leadership position in the transition of prescription drugs to film. Our patented PharmFilm® technology platform enables a wide range of pharmaceutical products to be delivered buccally, sublingually, enterally and through other mucosal surfaces for the improvement of healthcare for patients.

Partners and Licensing
Partnering with MonoSol Rx offers pharmaceutical companies the ability to introduce products that are highly differentiated from other dosage forms, both in performance and marketability, creating fresh, dynamic revenue-generating opportunities.